Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
STRONG BUY! Kurs eskaliert - A Star is Born!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
760 Leser
Artikel bewerten:
(2)

Focus Financial Partners Inc.: Ketoret Capital to Join Focus Partner Firm Telemus Capital, Further Expanding Telemus' Presence in the Chicago Wealth Management Market

Finanznachrichten News

NEW YORK, NY / ACCESSWIRE / November 16, 2023 / Focus Financial Partners ("Focus"), a leading partnership of independent, fiduciary wealth management firms, announced today that it has entered into a definitive agreement under which Ketoret Capital, LLC ("Ketoret"), located in Wood Dale, Illinois, will join Focus partner firm Telemus Capital, LLC ("Telemus"), headquartered in Southfield, Michigan. This transaction is expected to close in the first quarter of 2024, subject to customary closing conditions.

The Ketoret team, led by founder and CEO Kirill Vorobeychik, is known for its personalized advice and dedication to client-first service. Ketoret guides its clients through a comprehensive financial planning process and supports clients and their families based on their individual circumstances. Ketoret's clients will benefit from the broader resources and infrastructure available through Telemus, and Telemus will add a talented team.

"After a rigorous process to identify a strategic partner, I felt there was a great fit with a team that had the same level of commitment to client care that our clients have become accustomed to," said Kirill Vorobechik. "We expect this transaction to enhance the services and resources we can offer our clients, and to provide our team with a seamless transition that will equip them with tools to enhance our clients' experiences."

Telemus CEO Lyle Wolberg added, "We have gotten to know Kirill, his team and their unwavering commitment to their clients, and believe our firms coming together will add talented professionals and a strong base of clients to our growing team in that wealth market."

"We are delighted that Ketoret will be joining Telemus," said Pradeep Jayaraman, Managing Director - Co-Head Partnerships and Business Development for Focus. "This transaction will enable Telemus to continue to add talent to its team and is another example of how we add value to our partners through our M&A expertise and extensive network of relationships in the industry, and our ability to provide solutions to advisors throughout the country, regardless of their individual situations or any unique circumstances."

About Focus Financial Partners

Focus Financial Partners is a leading partnership of independent, fiduciary wealth management firms. Focus provides access to best practices, resources, and continuity planning for its partner firms who serve individuals, families, employers and institutions with comprehensive wealth management services. Focus partner firms benefit from the synergies, scale, economics and best practices offered by Focus to achieve their business objectives. For more information about Focus, please visit www.focusfinancialpartners.com.

About Telemus Capital, LLC

Telemus Capital, LLC is an independent investment adviser headquartered in Southfield, MI with offices in Ann Arbor, MI and Chicago, IL. The firm provides wealth management, investment management and financial planning services to individuals and families seeking impartial advice and long-term financial security. For more information about Telemus, please visit www.telemus.com.

Media Contact

Travis Danysh
Managing Director
Focus Financial Partners
P: +646-518-1342
TDanysh@focuspartners.com

SOURCE: Focus Financial Partners

View source version on accesswire.com:
https://www.accesswire.com/804548/correction-by-source-ketoret-capital-to-join-focus-partner-firm-telemus-capital-further-expanding-telemus-presence-in-the-chicago-wealth-management-market

© 2023 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.